News
Hosted on MSN10m
Gilead gets positive EU regulatory opinion for seladelparGilead Sciences (NASDAQ:GILD) has received a positive recommendation for approval from European regulators for its drug seladelpar for the treatment of primary biliary cholangitis, or PBC, a rare ...
Topline data were announced from a phase 2/3 trial evaluating tovecimig plus paclitaxel in patients with advanced biliary tract cancer.
The patient was diagnosed with nongerminal-center B cell diffuse large B-cell lymphoma (DLBCL) 1 year after being diagnosed with primary biliary cholangitis (PBC).
Ipsen has announced that its Iqirvo (elafibranor) tablets have been accepted by the Scottish Medicines Consortium (SMC) to ...
Jo McCardle, 52, said she went through a 'really dark time' after she was told she had Primary Biliary Cholangitis - a liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results